Nintedanib slows lung function decline in systemic sclerosis patients: New study highlights promising results
Glycoprotein acetyls: A game-changing biomarker for cardiovascular risk in rheumatoid arthritis patients
Secukinumab 150 mg effective in reducing NSAID dependence for ankylosing spondylitis: ASTRUM study breakthrough
Tocilizumab offers hope for rheumatoid arthritis with interstitial lung disease, but caution advised against respiratory infections
